1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Purdue

Anonymous board for Purdue.


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    13
    Views:
    2,080
  2. anonymous
    Replies:
    6
    Views:
    876
  3. anonymous
    Replies:
    32
    Views:
    2,612
  4. anonymous
    Replies:
    42
    Views:
    11,236
  5. anonymous
    Replies:
    14
    Views:
    1,930
  6. anonymous
    Replies:
    13
    Views:
    1,611
  7. Paul Steffan
    Replies:
    0
    Views:
    577
  8. anonymous
    Replies:
    10
    Views:
    1,022
  9. anonymous
    Replies:
    0
    Views:
    668
  10. anonymous
    Replies:
    3
    Views:
    512
  11. anonymous
    Replies:
    0
    Views:
    828
  12. anonymous
    Replies:
    3
    Views:
    2,123
  13. Marv Kelly
    Replies:
    35
    Views:
    13,040
  14. anonymous
    Replies:
    1
    Views:
    1,677
  15. anonymous
    Replies:
    3
    Views:
    1,320
  16. anonymous
    Replies:
    33
    Views:
    11,367
  17. anonymous
    Replies:
    17
    Views:
    5,106
  18. anonymous
    Replies:
    11
    Views:
    3,201
  19. Patrick Radden Keefe
    Replies:
    4
    Views:
    1,694
  20. anonymous
    Replies:
    2
    Views:
    798

Thread Display Options

Loading...